Product Information
FLU HBP 325-2-10 MG CAPLET is a generic product labeled by Cardinal Health, priced at $0.0959 per EA under NDC 70000005001. Its NADAC has been published 185 times since Mar 22, 2023.
FLU HBP 325-2-10 MG CAPLET
Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBrStrength
325; 2; 10 mg/1; mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000005001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/17/2020
Pharmacological Classes
Price Statistics
The NADAC for FLU HBP 325-2-10 MG CAPLET has been published 185 times since Mar 22, 2023, and over the history we have for it it has risen 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0959 per EA |
|---|---|
| All-time high | $0.1525 (Jul 10, 2024) |
| All-time low | $0.0859 (Mar 22, 2023) |
| 52-week high | $0.1241 |
| 52-week low | $0.0959 |
| Median price | $0.1099 |
| Average price | $0.1231 |
| Largest weekly change | +47.8% (Feb 21, 2024) |
| Weeks tracked | 185 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLU HBP 325-2-10 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for FLU HBP 325-2-10 MG CAPLET, manufactured by Cardinal Health, is $0.0959 per EA (NDC 70000005001), effective Sep 30, 2026.
How has the price of FLU HBP 325-2-10 MG CAPLET changed over time?
Over the history we have for it, the NADAC for FLU HBP 325-2-10 MG CAPLET has risen 11.7%. It has been tracked across 185 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for FLU HBP 325-2-10 MG CAPLET?
Since Mar 22, 2023, the NADAC for FLU HBP 325-2-10 MG CAPLET has ranged from a low of $0.0859 (Mar 22, 2023) to a high of $0.1525 (Jul 10, 2024), with a median of $0.1099 per EA.
Are there cheaper alternatives to FLU HBP 325-2-10 MG CAPLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLU HBP 325-2-10 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FLU HBP 325-2-10 MG CAPLET?
FLU HBP 325-2-10 MG CAPLET (NDC 70000005001) is labeled by Cardinal Health, and CMS classifies it as a generic product.